4//SEC Filing
Ndu Adora 4
Accession 0001415889-25-015274
CIK 0001070494other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 6:05 PM ET
Size
11.7 KB
Accession
0001415889-25-015274
Insider Transaction Report
Form 4
Ndu Adora
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-05-29−9,387→ 0 total→ Common Stock (9,387 underlying) - Award
Director Stock Options (Right to Buy)
2025-05-29+13,793→ 13,793 totalExercise: $22.29Exp: 2035-05-28→ Common Stock (13,793 underlying) - Award
Restricted Stock Units
2025-05-29+8,107→ 8,107 total→ Common Stock (8,107 underlying) - Exercise/Conversion
Common Stock
2025-05-29+9,387→ 24,801 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F2]The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held.
- [F3]The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders.
- [F4]The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001865210
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 6:05 PM ET
- Size
- 11.7 KB